Michaela Schulz-Siegmund

Dr. Michaela Schulz-Siegmund

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2008 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
KLKatrin Lorenz
Katrin Lorenz
MSMarit Sicker
Marit Sicker
ESEva Schmelzer
Eva Schmelzer
TRThomas Rupf
Thomas Rupf
JSJuergen Salvetter
Juergen Salvetter
ABAugustinus Bader
Augustinus Bader

9 August 2002 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
KKKarin Kellner
Karin Kellner
GLGregor Liebsch
Gregor Liebsch
IKIngo Klimant
Ingo Klimant
OWOtto S. Wolfbeis
Otto S. Wolfbeis
TBTorsten Blunk
Torsten Blunk
AGAchim Göpferich
Achim Göpferich

1 November 2005 in Tissue Engineering
Verified
Journal Article
Closed access
MNMarkus Neubauer
Markus Neubauer
MHMichael Hacker
Michael Hacker
PBPetra Bauer-Kreisel
Petra Bauer-Kreisel
BWBarbara Weiser
Barbara Weiser
CFClaudia Fischbach
Claudia Fischbach
TBTorsten Blunk
Torsten Blunk
Despite the clinical need for reconstructive and plastic surgery, the supply of engineered adipose tissue equivalents still remains a challenge. As yet, only preadipocytes have been applied as a cell material for the in vitro tissue engineering of fat. Herein, we report the establishment of a three-dimensional (3-D) long-term cell culture, using bone marrow-derived mesenchymal stem cells (MSCs) as an alternative cell source and custom-made poly(lactic-co-glycolic acid) (PLGA) scaffolds as a cell carrier. Cell-polymer constructs were cultivated for 4 weeks in both the absence and presence of basic fibroblast growth factor (bFGF), which was previously shown to strongly enhance the adipogenesis of MSCs in conventional 2-D short-term culture. A striking enhancement of the adipogenic differentiation of MSCs and tissue development caused by bFGF in the 3-D culture was observed by osmium tetroxide histology and scanning electron microscopy. At the molecular level, reflecting the increased accumulation of lipids, bFGF increased the enzymatic activity of glycerol-3-phosphate dehydrogenase, a late marker of adipogenesis, and the expression of adipocyte-specific genes peroxisome proliferator activated receptor-gamma2 (PPARgamma2) and glucose transporter-4 (GLUT4), as assessed by reverse transcription-polymerase chain reaction. This study demonstrates that the use of bone marrow-derived MSCs, especially in combination with bFGF, may represent a promising approach to adipose tissue engineering.

1 June 2021 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MSMichaela Schulz-Siegmund
Michaela Schulz-Siegmund
AAAchim Aigner
Achim Aigner


19 October 2004 in FEBS Letters
Verified
Journal Article
Closed access
MNMarkus Neubauer
Markus Neubauer
CFClaudia Fischbach
Claudia Fischbach
PBPetra Bauer-Kreisel
Petra Bauer-Kreisel
ELEsther Lieb
Esther Lieb
MHMichael Hacker
Michael Hacker
TBTorsten Blunk
Torsten Blunk